CIK 0001297184 · Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 330702205
- Phone
- 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- 8-K Event Material agreement
- 4 Grant or award CFO, EVP & Treasurer acquired 23,925 shares (grant or award)
- 4 Grant or award EVP Corp Admin Center acquired 12,752 shares (grant or award)
- 4 Grant or award EVP, Production Center acquired 15,129 shares (grant or award)
- 4 Grant or award CEO & Chief Scientific Officer acquired 115,684 shares (grant or award)
- 4 Open-market sale CFO, EVP & Treasurer sold 10,974 shares at $36.33 ($398,685)
- 4 Open-market sale Director sold 500 shares at an average $36.70 ($18,349)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Bylaws or fiscal year change
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Director sold 500 shares at $30.35 ($15,176)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Director sold 500 shares at $27.94 ($13,971)
- 4 Open-market sale Director sold 500 shares at $30.13 ($15,067)
- 8-K Event Material agreement
Page 16 of 48 · 958 filings